Last reviewed · How we verify
Other DTap Vaccines
Other DTap Vaccines is a Biologic drug developed by Sanofi Pasteur, a Sanofi Company. It is currently in Phase 2 development. Also known as: DAPTACEL®, INFANRIX®, PEDIARIX®, TRIPEDIA®.
At a glance
| Generic name | Other DTap Vaccines |
|---|---|
| Also known as | DAPTACEL®, INFANRIX®, PEDIARIX®, TRIPEDIA® |
| Sponsor | Sanofi Pasteur, a Sanofi Company |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to a Meningococcal Reference Vaccine, and When Given Alone or With Two Other Vaccines in Healthy Adolescents (PHASE3)
- Safety of Simultaneous mRNA COVID-19 Vaccine With Other Childhood Vaccines in Young Children (PHASE4)
- The COVID-19 VaccinE Response and Co-Administration in Rheumatology Patients (COVER-CoAd) (PHASE4)
- Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine When Co-administered With Routine Pediatric Vaccines in Healthy Infants and Toddlers in Europe (PHASE3)
- GBS-NN/NN2 (50 µg of Each Fusion Protein [GBS-NN and GBS-NN2] in Combination With 500 µg Aluminum as Alhydrogel®) Given With and Without the Tdap Vaccine in Healthy Non-pregnant Women 18 to 49 Years of Age (PHASE2, PHASE3)
- A Safety Study of Sabin Inactivated Poliovirus Vaccine in Infants (PHASE4)
- Phase I Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed . (PHASE1)
- The Safety of Boostrix Following Routine Immunization of Pregnant Women
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Other DTap Vaccines CI brief — competitive landscape report
- Other DTap Vaccines updates RSS · CI watch RSS
- Sanofi Pasteur, a Sanofi Company portfolio CI
Frequently asked questions about Other DTap Vaccines
What is Other DTap Vaccines?
Other DTap Vaccines is a Biologic drug developed by Sanofi Pasteur, a Sanofi Company.
Who makes Other DTap Vaccines?
Other DTap Vaccines is developed by Sanofi Pasteur, a Sanofi Company (see full Sanofi Pasteur, a Sanofi Company pipeline at /company/sanofi).
Is Other DTap Vaccines also known as anything else?
Other DTap Vaccines is also known as DAPTACEL®, INFANRIX®, PEDIARIX®, TRIPEDIA®.
What development phase is Other DTap Vaccines in?
Other DTap Vaccines is in Phase 2.
Related
- Manufacturer: Sanofi Pasteur, a Sanofi Company — full pipeline
- Also known as: DAPTACEL®, INFANRIX®, PEDIARIX®, TRIPEDIA®
- Compare: Other DTap Vaccines vs similar drugs
- Pricing: Other DTap Vaccines cost, discount & access